The report offers a latest study about the present worldwide market development strategy, pre and post covid-19 situation, by latest trends and drivers, and type, application. The report on Whole Exome Sequencing market offers qualitative along with quantitative study in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, and forecast by 2021-2024.

Whole Exome Sequencing Market Report is projected to grow at a CAGR of XX% during the forecast period 2021-2024.

Company Coverage: -
- Agilent Technologies Inc.
- Ambry Genetics Corp.
- Beijing Genomics Institute
- Bio-Rad Laboratories Inc.
- Eurofins Scientific Group
- F. Hoffmann-La Roche AG
- GENEWIZ Inc.
- Illumina Inc.
- Macrogen Inc.
- Pacific Biosciences of California Inc.

Scope: -
Exome sequencing is a technique for sequencing all of the exome and protein-coding genes in a genome. This technique includes selection of the subset of DNA that encodes proteins or exons, followed by sequencing of the exonic DNA using high-throughput DNA sequencing methods. Currently, it is being widely used for the identification and the determination of genetic variants causing various diseases, such as Miller syndrome and Alzheimer's disease. It also provides a cost-effective screening approach for the diagnosis of genetic disorders, and presents itself as a less resource-intensive alternative to whole genome sequencing in several applications, including drug discovery and development processes.

Regions: -

- North America

- Asia-Pacific

- Europe

- South America

- Africa


Key Highlights of Report:

- Provides market definition and overview by studying objectives like market scope and market size estimation.
- Provides research methods and logic based on historic data.
- Analysis market competition, market performance worldwide, manufactures basic information, Sales, Value, Price and Gross Margin.
- Analysis on segmentation of types, applications and regions based on historical Data and market forecasts.